2-chloroadenosine has been researched along with Duncan Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baron, J; Lin, H; Penumalli, V; Rezania, K; Soliven, B; van Besien, K | 1 |
| Adamczyk-Cioch, M; Błasińska-Morawiec, M; Dmoszyńska, A; Dwilewicz-Trojaczek, M; Hellmann, A; Kazimierczak, M; Krykowski, E; Kuratowska, Z; Lewandowski, K; Nowak, WS; Robak, T; Skotnicki, AB; Trepińska, E; Urasiński, I; Zdziarska, B | 1 |
| Bolam, S; Orchard, JA; Oscier, DG | 1 |
| Dumontet, C; Galmarini, CM; Mackey, JR | 1 |
| Juliusson, G; Liliemark, J | 1 |
2 review(s) available for 2-chloroadenosine and Duncan Disease
| Article | Year |
|---|---|
Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature.
Topics: 2-Chloroadenosine; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; Deoxyadenosines; Fatal Outcome; Female; Humans; Lymphoma; Lymphoma, Follicular; Lymphoproliferative Disorders; Male; Middle Aged; Myasthenia Gravis; Paraneoplastic Syndromes, Nervous System; Prednisone; Pyridostigmine Bromide; Recurrence; Remission Induction; Rituximab; Waldenstrom Macroglobulinemia | 2012 |
Nucleoside analogues: mechanisms of drug resistance and reversal strategies.
Topics: 2-Chloroadenosine; 5'-Nucleotidase; Acute Disease; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Biological Transport; Carrier Proteins; Cytarabine; Cytidine Deaminase; Cytosine; Deoxyadenosines; Deoxycytidine; Deoxycytidine Kinase; Dioxolanes; DNA Repair; DNA Replication; DNA-Directed DNA Polymerase; Drug Resistance, Neoplasm; Gemcitabine; Hematopoietic Cell Growth Factors; Humans; Leukemia, Myeloid; Lymphoproliferative Disorders; Neoplastic Stem Cells; Nucleosides; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Remission Induction; Ribonucleotide Reductases; Vidarabine | 2001 |
3 other study(ies) available for 2-chloroadenosine and Duncan Disease
| Article | Year |
|---|---|
2-Chlorodeoxyadenosine (cladribine)-related eosinophilia in patients with lymphoproliferative diseases.
Topics: 2-Chloroadenosine; Aged; Antimetabolites, Antineoplastic; Deoxyadenosines; Eosinophilia; Female; Humans; Infusions, Intravenous; Leukocyte Count; Lymphoproliferative Disorders; Male; Middle Aged; Retrospective Studies | 1997 |
Association of myelodysplastic changes with purine analogues.
Topics: 2-Chloroadenosine; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Deoxyadenosines; Female; Humans; Lymphoproliferative Disorders; Male; Myelodysplastic Syndromes; Pentostatin; Vidarabine | 1998 |
[A new effective therapy of hairy cell leukemia and other lymphoproliferative diseases].
Topics: 2-Chloroadenosine; Cladribine; Deoxyadenosines; Humans; Leukemia, Hairy Cell; Lymphoproliferative Disorders | 1991 |